253 related articles for article (PubMed ID: 11264235)
1. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
Tatarczyńska E; Klodzińska A; Chojnacka-Wójcik E; Palucha A; Gasparini F; Kuhn R; Pilc A
Br J Pharmacol; 2001 Apr; 132(7):1423-30. PubMed ID: 11264235
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A
Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats.
Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Pilc A
Pol J Pharmacol; 2000; 52(6):463-6. PubMed ID: 11334240
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.
Spooren WP; Vassout A; Neijt HC; Kuhn R; Gasparini F; Roux S; Porsolt RD; Gentsch C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1267-75. PubMed ID: 11082464
[TBL] [Abstract][Full Text] [Related]
5. Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats.
Pilc A; Kłodzińska A; Brański P; Nowak G; Pałucha A; Szewczyk B; Tatarczyńska E; Chojnacka-Wójcik E; Wierońska JM
Neuropharmacology; 2002 Aug; 43(2):181-7. PubMed ID: 12213272
[TBL] [Abstract][Full Text] [Related]
6. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison.
Ballard TM; Woolley ML; Prinssen E; Huwyler J; Porter R; Spooren W
Psychopharmacology (Berl); 2005 Apr; 179(1):218-29. PubMed ID: 15739074
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
[TBL] [Abstract][Full Text] [Related]
8. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A
Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone.
Brodkin J; Busse C; Sukoff SJ; Varney MA
Pharmacol Biochem Behav; 2002 Sep; 73(2):359-66. PubMed ID: 12117590
[TBL] [Abstract][Full Text] [Related]
10. Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.
Porter RH; Jaeschke G; Spooren W; Ballard TM; Büttelmann B; Kolczewski S; Peters JU; Prinssen E; Wichmann J; Vieira E; Mühlemann A; Gatti S; Mutel V; Malherbe P
J Pharmacol Exp Ther; 2005 Nov; 315(2):711-21. PubMed ID: 16040814
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice.
Li X; Need AB; Baez M; Witkin JM
J Pharmacol Exp Ther; 2006 Oct; 319(1):254-9. PubMed ID: 16803860
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats.
Wieronska JM; Szewczyk B; Branski P; Palucha A; Pilc A
Amino Acids; 2002; 23(1-3):213-6. PubMed ID: 12373540
[TBL] [Abstract][Full Text] [Related]
13. Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test.
Steckler T; Lavreysen H; Oliveira AM; Aerts N; Van Craenendonck H; Prickaerts J; Megens A; Lesage AS
Psychopharmacology (Berl); 2005 Apr; 179(1):198-206. PubMed ID: 15821950
[TBL] [Abstract][Full Text] [Related]
14. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
[TBL] [Abstract][Full Text] [Related]
15. In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling.
Wierońska JM; Smiałowska M; Brański P; Gasparini F; Kłodzińska A; Szewczyk B; Pałucha A; Chojnacka-Wójcik E; Pilc A
Neuropsychopharmacology; 2004 Mar; 29(3):514-21. PubMed ID: 14666119
[TBL] [Abstract][Full Text] [Related]
16. Effects of a metabotropic, mglu5, glutamate receptor antagonist on ethanol consumption by genetic drinking rats.
McMillen BA; Crawford MS; Kulers CM; Williams HL
Alcohol Alcohol; 2005; 40(6):494-7. PubMed ID: 16186143
[TBL] [Abstract][Full Text] [Related]
17. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
[TBL] [Abstract][Full Text] [Related]
18. The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug.
Inta D; Filipovic D; Lima-Ojeda JM; Dormann C; Pfeiffer N; Gasparini F; Gass P
Neuropharmacology; 2012 Apr; 62(5-6):2034-9. PubMed ID: 22261382
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.
Belozertseva IV; Kos T; Popik P; Danysz W; Bespalov AY
Eur Neuropsychopharmacol; 2007 Feb; 17(3):172-9. PubMed ID: 16630709
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.
Sławińska A; Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Uberti MA; Bacolod MA; Doller D; Pilc A
Neuropharmacology; 2013 Mar; 66():225-35. PubMed ID: 22634361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
